Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05014659 · ClinicalTrials.gov registry record · NA
Creatine Monohydrate Supplementation and Vascular Endothelial Health
A NA study of Endothelial Dysfunction and Oxidative Stress, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT05014659: Completed NA study of Endothelial Dysfunction and Oxidative Stress, sponsored by Florida State University.
NCT05014659 is a NA study of Endothelial Dysfunction and Oxidative Stress that has completed, run by Florida State University. The registered enrollment target is 12 participants, below the 92-participant average among 45 other Endothelial Dysfunction trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05014659, a NA study of Endothelial Dysfunction and Oxidative Stress, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the effects of 4 weeks of creatine monohydrate supplementation on markers of macrovascular and microvascular function, cognitive performance, and physical performance.
Primary Outcome
FMD% is a validated, non-invasive, standardized method of measuring the ability of an artery to respond to a stimulated increase in blood flow via vasodilation. Increase in blood flow will be stimulated by inflating a forearm cuff for 5 minutes, then rapidly releasing this cuff. Brachial artery in the participants right arm will be identified/imaged using a Philips Doppler Ultrasound. Resting diameter will be measured in millimeters, and max dilation will be the maximum diameter in millimeters f
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Creatine monohydrate
Study Locations (1)
Florida
- Sandels Building - Tallahassee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-10-17 |
| Est. Completion | 2022-12-12 |
| Phase | NA |
What the finished NCT05014659 record still lists
NCT05014659 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 92-participant average among 45 other Endothelial Dysfunction trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Endothelial Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05014659 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05014659 about?
NCT05014659 is a clinical study titled "Creatine Monohydrate Supplementation and Vascular Endothelial Health". To determine the effects of 4 weeks of creatine monohydrate supplementation on markers of macrovascular and microvascular function, cognitive performance, and physical performance.
What is the current status of trial NCT05014659?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2020-10-17. Estimated completion is 2022-12-12.
What conditions does trial NCT05014659 study?
This clinical trial studies the following conditions: Endothelial Dysfunction, Oxidative Stress.
What interventions are being tested in trial NCT05014659?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Creatine monohydrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05014659?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05014659 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endothelial Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05014659's enrollment target sits among peer trials
12 45th of 45 higher than 1 of 45 other Endothelial Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endothelial Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
ACEs, SIRT1, and Premature Vascular Aging in Humans
RECRUITING · NA
-
Sodium Lowering Vascular Effects Trial
RECRUITING · NA
-
NightWare and Cardiovascular Health in Veterans With PTSD
RECRUITING · NA
-
Bright Light Exposure in Surgical Patients
RECRUITING · NA
-
Microvascular Dysfunction in Obesity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI